Cardior Pharmaceuticals is based in Hanover, Germany. It has raised $94M in total funding. Latest round: Series B.
Cardior Pharmaceuticals is based in Hanover, Germany. Cardior Pharmaceuticals has raised $94M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Cardior Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Life Sciences Partners, Boehringer Ingelheim Venture Fund, Bristol-Myers Squibb, BioMedPartners, High-Tech Gründerfonds, Inkef and 1 others. 7 distinct backers are named across the disclosed rounds.
Round data for Cardior Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Hanover and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026